New York, NY, November 9, 2009-Ebitda News reports that negative EBITDA for Anadys Pharmaceuticals, Inc. (NASDAQ:ANDS) for its quarter ended September 30, 2009 was $(5,761,000), a 38% improvement over ... read full story
Stocks are mixed at midday after falling lower on a Wall Street rumor that the Fed may come out and raise the discount window today. Investors are digesting a flurry of mixed economic releases today that included data regarding the labor market, infl ... read full story
+0.06 
